![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
AJ Carter
Department of Pharmacology, Boehringer Ingelheim KG, Ingelheim/Rhein, Federal Republic of Germany.
Antagonists of the NMDA receptor-channel complex may be useful for the treatment of thrombotic stroke, head injury and epilepsy. Their clinical use, however, could be limited by the incidence of side effects such as ataxia. I have therefore investigated the relationship between functional antagonism of the N-methyl-D-aspartate (NMDA) receptor-channel complex in vivo and disturbances of motor coordination. Antagonism of the NMDA receptor-channel complex was assessed by measuring a compounds ability to inhibit NMDA-induced lethality in mice, disturbances of motor coordination were measured by the rotarod technique. NMDA dose-dependently induced convulsions and ultimately caused death in mice (LD50 = 137 +/- 4 mg/kg i.p.). Noncompetitive NMDA antagonists of either an arylcyclohexylamine (phencyclidine, (+)/(-)-MK-801 [10-11-dihydro-5-methyl-5H-dibenzo[a,d] cyclohepten-5,10-imine hydrogen maleate] and ketamine) or a benzomorphan (dextrorphan and N-allylnormetazocine) structure, competitive antagonists (CGP 37849 [(R,S)-(E)-2-amino-4-methyl-5- phosphono-3-pentenoic acid monohydrate] and CGP 39551 [(R,S)-(E)-2- amino-4-methyl-5-phosphono-3-pentenoic acid 1-ethyl ester]) or a glycine site antagonist (L-687,414 [(3R,4R)-3-amino-4-methyl-1-hydroxy- pyrrolidin-2-one-(-)-tartrate salt]) inhibited NMDA-induced lethality after s.c. administration. These compounds also interfered with motor coordination. There was an excellent correlation (r = 0.97) between the two effects.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  C. D. Bryant, S. Eitan, K. Sinchak, M. S. Fanselow, and C. J. Evans NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL/6J mice Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R315 - R326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yamashita, K. Ohno, Y. Amada, H. Hattori, Y. Ozawa-Funatsu, T. Toya, H. Inami, J.-I. Shishikura, S. Sakamoto, M. Okada, et al. Effects of 2-[N-(4-Chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an Orally Active {alpha}-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonist, in Models of Generalized Epileptic Seizure in Mice and Rats J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Allen, A. L. Granger, and L. A. Dykstra The Competitive N-Methyl-D-aspartate Receptor Antagonist (-)-6-Phosphonomethyl-deca-hydroisoquinoline-3-carboxylic Acid (LY235959) Potentiates the Antinociceptive Effects of Opioids That Vary in Efficacy at the {micro}-Opioid Receptor J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 785 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Allen and L. A. Dykstra N-Methyl-D-Aspartate Receptor Antagonists Potentiate the Antinociceptive Effects of Morphine in Squirrel Monkeys J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 288 - 297. [Abstract] [Full Text]
|
|
|
|
|
|
A. G. Kanthasamy, R. J. Yun, B. Nguyen, and a. d. d. truong Effect of Riluzole on the Neurological and Neuropathological Changes in an Animal Model of Cardiac Arrest-Induced Movement Disorder J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1340 - 1348. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. Danysz and C. G. Parsons Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications Pharmacol. Rev., December 1, 1998; 50(4): 597 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Monaghan and H. Larsen NR1 and NR2 Subunit Contributions to N-Methyl-D-aspartate Receptor Channel Blocker Pharmacology J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 614 - 620. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. J. Carter, M. Grauert, U. Pschorn, W. D. Bechtel, C. Bartmann-Lindholm, Y. Qu, T. Scheuer, W. A. Catterall, and T. Weiser Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL PNAS, April 25, 2000; 97(9): 4944 - 4949. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
